Edoxaban for TIA and Acute Minor Stroke
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 3700 participants.
Also called NCT02221102
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 3,700 participants
- Sponsor
- Registry
-
NCT02221102
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02221102. Randomized; triple masking; primary purpose treatment. Start 2013-12 (registry gives no type); primary completion 2015-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Edoxaban for TIA and Acute Minor Stroke
- Condition
- Ischemia
- Condition
- Stroke
- Condition
- Cerebral Infarction
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- edoxaban
- Intervention (Drug)
- placebo
- Lead sponsor
- Xijing Hospital
Record details
- Record id
cardio:ct-nct02221102- Content hash
d710117e2aa45106368bc0b1f3ce0aeb2823c6ca65f97c5336669ef3b1f9f59b